USPTO 2015–2025 USPTO PatentsView US Corporation

Inogen, Inc.

USPTO PatentsView assignee record - 36 granted patents across 16 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

RSS updates for this company

The verdict

According to USPTO PatentsView, Inogen ranks #8,833 of 49,997 tracked US assignees by granted-patent volume, with 36 patents across 16 technology areas.

#8,833
of 49,997 US assignees by volume
Top 31%
by Innovation Score (42.4/100)
13.5
avg claims per patent
+350%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8833 · US Corporation #8,833 · 36 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 36 grants
  • UPPER-Q #8,833/49,997
  • PHOTO-FINISH Indivior UK
  • CPC-FOCUS A61M · 16 areas
  • INNOV-PAR 42.4/100
  • CLAIMS-RICH 13.5 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +350% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Indivior UK Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Inogen’s 42.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Inogen

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Inogen's Innovation Score is 42.4/100 (top 31% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Inogen?

Each dot is one of Inogen’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Inogen’s own 13.5 claims/patent is at or below the 17.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Inogen vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 35.936.036.03636.036.036.1 0102030 Granted patents (volume) Avg claims / patent Ipsen Biopharm Limited - 36, 17.11Ipsen BiopharmIsara Corporation - 36, 24.89IsaraIndivior UK Limited - 36, 24.33Indivior UKIndyme Solutions, LLC - 36, 13.39Indyme SolutionsIntellective Ai, Inc. - 36, 20.06Intellective AiIntellectual Property Innovation Corporation - 36, 17.89Intellectual Prop…Isolynx, LLC - 36, 16.97IsolynxJBL International, Inc - 36, 1.22JBL InternationalInogen, Inc. - 36, 13.53Inogen
Inogen vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Inogen's grants concentrate

Inogen, Inc. is a focused PatentsView assignee: 16 CPC subclasses with 75% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2020 (7 grants) versus a trough of 1 in 2015. By volume, Inogen sits between Ipsen Biopharm Limited and JBL International, Inc.

Inogen's three-year grant acceleration

Inogen, Inc. shows 15 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Inogen's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Inogen holds 36 patents at rank #8,839, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Inogen

By rank, the assignees closest to #8,839 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Inogen's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Inogen, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), Inogen ranks #261 of 3,490 assignees by patent count in that subclass.

Inogen's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 31% higher than 69% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 20152016201720182019202020212022202320242025 3
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Inogen, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 2.8%
2016 2 5.6%
2017 1 2.8%
2018 1 2.8%
2019 1 2.8%
2020 7 19.4%
2021 5 13.9%
2022 5 13.9%
2023 6 16.7%
2024 4 11.1%
2025partial year 3 8.3%

Which technologies does Inogen, Inc. patent most?

Top 15 of 16 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Inogen, Inc.'s patent record in context - here's where to go next.

  • Inogen, Inc.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 75% of its portfolio - see every assignee active in that class. Explore A61M
  • Ranked #8,833 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Inogen, Inc. against Ipsen Biopharm Limited, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 42.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.